Thanks Kevin, and good morning everyone. I'd like to start off with saying we had a good year. We executed strongly, both financially and operationally during the quarter and the year. Today, I will divide my remarks between our fourth quarter and year-end 2019 results. I'll first discuss our consolidated financial performance before moving on to our segment results, investment portfolio returns and finally capital activities. Starting with our consolidated results and beginning with the fourth quarter where our annualized return on average common equity was 2.5% and our annualized operating return on average common equity was 1.7%. Gross premiums written for the quarter were $905 million, up $358 million or 65% from the comparable quarter last year. About two-thirds of this was organic growth. We reported net income for the quarter of $34 million or $0.77 per diluted common share. Our operating income was $23 million or $0.52 per diluted common share. Operating income excludes $18 million of net realized and unrealized gains on investments and $5.7 million of transaction, integration and compensation expenses associated with the TMR integration. We had an underwriting loss for the quarter of $65 million and reported an overall combined ratio of 106.7%. Now, before moving on to our full year results, I'd like to provide more clarity on how the non-controlling interest from our joint ventures impact our financial statements. Each quarter, we fully consolidate the results of DaVinci, Medici and Vermeer, and since we do not own 100% of these entities, we removed a portion of their returns that we do not own. For example, a 100% of DaVinci's results are included in our underwriting and investment income. However, because we only own 22% of DaVinci, we removed 78% of the DaVinci's returns from our net income. This elimination is reflected in the income statement as the net loss or income attributable to non-controlling interests. Therefore, when these ventures produce positive returns, the elimination of the income attributable to third party investors is reflected as a reduction to our net income. Likewise, when these ventures have negative results, the elimination is reflected as an increase to our net income. We have added a new page to the financial supplement that provides a breakdown of the components of the non-controlling interest adjustment. This has always been reflected in our 10-K and 10-Q, but given the increasing significance, we thought it would be helpful if we included it in the financial supplement. As you will see in the new disclosure, for the quarter, we reflected a positive non-controlling interest of $2.6 million, where both Vermeer and Medici produced positive returns for the quarter, and these were more than offset by negative returns in DaVinci, resulting in a net overall loss for these vehicles, which is reflected as a positive noncontrolling interest adjustment. And moving on to the full year 2019 where we grew our book value per share by 15.7% and tangible book value per share, plus accumulated dividends by 17.9%. We realized a return on average common equity of 14.1% and an operating return on average common equity of 8%. We reported net income of $712 million for the year or $16.29 per diluted common share, and our operating income was $403 million or $9.13 per diluted common share. In 2019, our overall combined ratio was 92.3%. Net premiums earned for 2019 were $3.3 billion, up $1.4 billion or 69% year-over-year. Now before moving to our segment results, I'd like to update you on our operational efficiency. Our direct expenses, which are the sum of our operational and corporate expenses totaled $82 million for the quarter, which is an increase of $11 million from the fourth quarter of 2018. However, the ratio of direct expense to net premiums earned was 8.5%, a decrease of almost 4 percentage points for the same period last year. Likewise, for the year, direct expenses were up by $105 million to $317 million while the ratio of direct expense to net premiums earned decreased by 1.2 percentage points in 2019 to 9.5%. Adjusting for the impact of $50 million in TMR integration costs incurred in 2019, direct expenses would have been $267 million for the year or 8% of net premiums earned. Now moving on to our segments and starting with our Property segment, Property gross premiums written grew by $45 million or 23% over the comparative quarter to $245 million. This growth was driven by an increase in other Property of $109 million. The growth in other property was partially offset by $64 million decline in Property cat gross premiums written. We do not typically write much Property cat in the fourth quarter outside of reinstatement premiums, which were down this year reflective of loss activity and business mix. Other Property is becoming a larger percentage of our overall property book, and for the year, makes up 34% of Property gross premiums written compared to 23% in 2018. As a reminder, we access proportional business through our other Property book and due to the nature of this business, it carries a higher acquisition expense ratio. As this business becomes a greater part of the Property segment, acquisition expenses may increase. Our Property segment reported an underwriting loss of $87 million and a combined ratio of 118.6% in the fourth quarter, with Property catastrophe reporting a 141% combined ratio, and other Property reporting an 88.6% combined ratio. Current quarter losses in Property cat were primarily driven by Typhoon Hagibis. On our last call, we announced an estimated net negative impact for the fourth quarter related to the Typhoon Hagibis of approximately $175 million. We remain comfortable with this estimate. As you saw in our financials, we have allocated $128 million of net negative impact specifically to Hagibis with the remainder being incurred under our aggregate covers. So to be clear, our estimate has not changed. We have also reallocated $22 million in net negative impact from the third quarter events to 2019 aggregate losses. While this reallocation primarily relates to Typhoon Faxai, our estimates for both Faxai and Dorian remain the same at $103 million and $52 million respectively. For the year, gross premiums written in our Property segment grew by $670 million or 38%. This broke down to growth of $246 million or 18% in our Property catastrophe class of business and $424 million or 103% in our other Property class of business. For the full year, our Property segment reported underwriting income of $209 million and a combined ratio of 87%. Now moving on to the Casualty segment where our gross premiums written were up $313 million or 90% in the fourth quarter of 2019 over the comparative quarter, approximately two-thirds of this quarterly growth was organic. We reported underwriting income of $21 million and a combined ratio of 95.9% for the quarter. The current accident year loss ratio for the Casualty segment was 68%. For the year, gross premiums written were up $827 million or 53%, about half of this growth was organic. The segment reported underwriting income of $46 million and a combined ratio of 97% for the year. Now moving to fee income where total fee income was $13 million for the quarter with management fees contributing $24 million and performance fees being negative $11 million. The negative performance fees were driven by the cat activity in the quarter, primarily Hagibis which triggered the reversal of previously accrued performance fees. Overall, our quarterly fee income was up by $5 million relative to the comparable quarter. For the year, total fee income was $114 million, up $24 million from 2018. Now turning to investments, we posted total investment results of $131 million for the fourth quarter, which includes mark-to-market gains of $18 million. For the year, total investment results were $838 million with $415 million in mark-to-market gains. Our fixed maturity and short-term investment return for the quarter was $97 million and overall net investment income for the quarter was $113 million, almost flat compared to the third quarter. This quarter we have enhanced our disclosures in the financial supplement to include retained total investment result. This delineates the net investment income and mark-to-market results that apply to our retained investment portfolio. In short, this is the quarterly investment return that contributes to our net income and the remainder is what belongs to our partner capital. Of the $113 million of net investment income, we retained $91 million, a retention of about 80%, which is consistent with the full year 2019 and 2018. In the fourth quarter, our managed investment portfolio reported yield to maturity of 2.1% and duration of 2.9 years on assets of $15.7 billion, while our retained investment portfolio reported yield to maturity of 2.2% and duration of 3.6 years on assets of $11.2 billion. Now moving on to capital management, the fourth quarter was once again active from a capital management perspective. As Kevin mentioned, we had a successful capital raise in preparation for 1/1 renewals raising over $525 million in Upsilon and Medici, effective January 2020. This is in addition to the $1.3 billion in partner capital that we raised across our various joint ventures in 2019. Looking forward to 2020, on March 15th, the $250 million tranche of 5.75% senior notes will mature. As a reminder, last year we issued $400 million of 3.6% senior notes due in 2029. Consequently, we remain in a strong capital and liquidity position going into 2020 and with an improving interest rate environment, anticipate additional opportunities to deploy capital into the business. As such, we did not repurchase any of our shares during the fourth quarter. Before I turn it back over to Kevin, I want to update you on a change that we will be making to our operating income calculation, starting in the first quarter of 2020. As you know, operating income excludes net realized and unrealized gains on investments attributable to shareholders, transaction, integration and compensation expenses associated with the TMR acquisition and income tax impact associated with these exclusions. With the addition of TMR and their non-dollar balance sheet, we will be refining our methodology to also exclude foreign exchange gains and losses. While we hedge our economic FX exposure, we sometimes experience accounting driven volatility that over time should be relatively neutral in terms of bottom line impact. And finally, I'd like to update you on our TMR acquisition. With the 1/1 renewal behind us, we have reunderwritten effectively all of the TMR book, renewing the deals, which met our strategic and financial thresholds. We exceeded the two primary metrics that we set out at the time of the acquisition as we retained greater than $700 million of TMR premium and will achieve an after-tax earnings run rate contribution greater than $100 million by the end of Q1 2020. When I think about the integration, it's the operational successes behind the financial ones that are even more important. We have a single view of risk, our key systems are integrated, we have deepened our bench strength and our people are working extremely well together. Going into 2020, we will benefit from the increased scale and operational efficiency that TMR has brought us. Because of the significant time and effort we spent on integration activities in 2019, we are free from distraction and well positioned to capture opportunities in this improving market. And with that, I'll now turn it back over to Kevin for more details on our segments.